Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia.
about
The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy.The mitochondria permeability transition pore complex in the brain with interacting proteins - promising targets for protection in neurodegenerative diseases.Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Differential gene expression in human brain pericytes induced by amyloid-beta protein.Endogenous Expression of ODN-Related Peptides in Astrocytes Contributes to Cell Protection Against Oxidative Stress: Astrocyte-Neuron Crosstalk Relevance for Neuronal Survival.Protective effect of the octadecaneuropeptide on hydrogen peroxide-induced oxidative stress and cell death in cultured rat astrocytes.Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes.Beta-amyloid peptides stimulate endozepine biosynthesis in cultured rat astrocytes.The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway.Genetic loss of diazepam binding inhibitor in mice impairs social interest.
P2860
Q34395516-6777D2C0-283B-4EFA-A2AB-56B55C317B91Q35351209-0B68F0DC-5B0F-40D4-A7AB-7B48C171419CQ37724783-9D87EFF4-BCF4-40BA-A428-DC7254DDD44FQ37879217-E62D5B34-B001-4CAC-AD74-25D6D2EC3B6DQ38271572-8B71FB26-12C4-4A44-AE56-D908256E441AQ38340531-FA939822-3C1A-41C4-BA90-B373C253697AQ46306392-A376AC3C-16E6-42DF-BC0E-C54E9074F06FQ46594255-510464D1-1EC8-49B7-8990-85CC52BE6F90Q46610338-7502E194-F2EC-427F-8843-5216CC1548FDQ46610345-51629D3F-63AB-4184-9584-FBF22CDA064CQ46806237-00E313DD-3B73-48F5-9ADF-BDD682854B14Q47304071-CA54E1E0-3637-44AA-AE84-D207C404C216
P2860
Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Cerebrospinal fluid levels of ...... ative disorders with dementia.
@en
Cerebrospinal fluid levels of ...... ative disorders with dementia.
@nl
type
label
Cerebrospinal fluid levels of ...... ative disorders with dementia.
@en
Cerebrospinal fluid levels of ...... ative disorders with dementia.
@nl
prefLabel
Cerebrospinal fluid levels of ...... ative disorders with dementia.
@en
Cerebrospinal fluid levels of ...... ative disorders with dementia.
@nl
P2093
P921
P356
P1433
P1476
Cerebrospinal fluid levels of ...... ative disorders with dementia.
@en
P2093
Appollonio I
Ferrarese C
Frattola L
Meregalli S
P304
P356
10.1212/WNL.40.4.632
P407
P577
1990-04-01T00:00:00Z